cycloheximide has been researched along with Huntington Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alberty, A; Dose, T; Kosinski, CM; Noth, J; Oliva, S; Schiefer, J | 1 |
| Goto, J; Hazeki, N; Kanazawa, I; Nakamura, K | 1 |
2 other study(ies) available for cycloheximide and Huntington Disease
| Article | Year |
|---|---|
Huntington's disease transgenic mice are resistant to global cerebral ischemia.
Topics: Animals; Cycloheximide; Exons; Genetic Predisposition to Disease; Hippocampus; Humans; Huntingtin Protein; Huntington Disease; Immunity, Innate; Ischemic Attack, Transient; Mice; Mice, Transgenic; Mutation; Nerve Tissue Proteins; Nuclear Proteins | 2002 |
Rapid aggregate formation of the huntingtin N-terminal fragment carrying an expanded polyglutamine tract.
Topics: Animals; Blotting, Western; Cell Nucleus; COS Cells; Cycloheximide; Cytochalasin D; Cytoplasm; Exons; Humans; Huntingtin Protein; Huntington Disease; Molecular Weight; Nerve Tissue Proteins; Nocodazole; Nuclear Proteins; Paclitaxel; Peptide Fragments; Peptides; Protein Binding; Recombinant Fusion Proteins; Time Factors; Transfection; Tunicamycin | 1999 |